176 related articles for article (PubMed ID: 33242669)
1. Current strategies to minimize postoperative hematoma formation in patients undergoing cardiac implantable electronic device implantation: A review.
Mehta NK; Doerr K; Skipper A; Rojas-Pena E; Dixon S; Haines DE
Heart Rhythm; 2021 Apr; 18(4):641-650. PubMed ID: 33242669
[TBL] [Abstract][Full Text] [Related]
2. Device implantation for patients on antiplatelets and anticoagulants: Use of suction drain.
Mukherjee SS; Saggu D; Chennapragada S; Yalagudri S; Nair SG; CalamburNarasimhan
Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S389-S393. PubMed ID: 30595295
[TBL] [Abstract][Full Text] [Related]
3. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I).
Turagam MK; Nagarajan DV; Bartus K; Makkar A; Swarup V
J Interv Card Electrophysiol; 2017 Aug; 49(2):197-204. PubMed ID: 28413854
[TBL] [Abstract][Full Text] [Related]
4. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
[TBL] [Abstract][Full Text] [Related]
5. Pocket related complications following cardiac electronic device implantation in patients receiving anticoagulation and/or dual antiplatelet therapy: prospective evaluation of different preventive strategies.
Awada H; Geller JC; Brunelli M; Ohlow MA
J Interv Card Electrophysiol; 2019 Apr; 54(3):247-255. PubMed ID: 30460588
[TBL] [Abstract][Full Text] [Related]
6. Cardiac implantable electronic device hematomas: Risk factors and effect of prophylactic pressure bandaging.
Koh Y; Bingham NE; Law N; Le D; Mariani JA
Pacing Clin Electrophysiol; 2017 Jul; 40(7):857-867. PubMed ID: 28543543
[TBL] [Abstract][Full Text] [Related]
7. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
8. Use of oxidized regenerated cellulose to prevent pocket hematomas after cardiac electronic device implantation in patients on anticoagulants or dual antiplatelet therapy.
Chia PL; Foo D
Int J Cardiol; 2013 Oct; 168(4):4406-7. PubMed ID: 23706282
[No Abstract] [Full Text] [Related]
9. Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.
Essebag V; Healey JS; Joza J; Nery PB; Kalfon E; Leiria TLL; Verma A; Ayala-Paredes F; Coutu B; Sumner GL; Becker G; Philippon F; Eikelboom J; Sandhu RK; Sapp J; Leather R; Yung D; Thibault B; Simpson CS; Ahmad K; Toal S; Sturmer M; Kavanagh K; Crystal E; Wells GA; Krahn AD; Birnie DH
Circ Arrhythm Electrophysiol; 2019 Oct; 12(10):e007545. PubMed ID: 31610718
[TBL] [Abstract][Full Text] [Related]
10. Effect of a pocket compression device on hematomas, skin reactions, and comfort in patients receiving a cardiovascular implantable electronic device: a randomized controlled trial.
Hu J; Zheng J; Liu X; Li G; Xiao X
J Interv Card Electrophysiol; 2022 Mar; 63(2):275-281. PubMed ID: 33675448
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
12. Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M; Trevisan F; Scalone A; Marcantoni L; Sammarco G; Bertini M
Am J Cardiol; 2017 Apr; 119(7):1036-1040. PubMed ID: 28153344
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices.
Ishibashi K; Miyamoto K; Kamakura T; Wada M; Nakajima I; Inoue Y; Okamura H; Noda T; Aiba T; Kamakura S; Shimizu W; Yasuda S; Akasaka T; Kusano K
Heart Vessels; 2017 Mar; 32(3):333-340. PubMed ID: 27469320
[TBL] [Abstract][Full Text] [Related]
14. Local gentamicin-collagen sponge reduces cardiovascular implantable electronic device infections and pocket hematoma.
Monaco C; Barone L; Cammalleri V; Stifano G; Magliano G; Geuna F; Romeo F; Sergi D
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5218-5224. PubMed ID: 35916820
[TBL] [Abstract][Full Text] [Related]
15. Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.
Atreya AR; Cook JR; Lindenauer PK
Postgrad Med; 2016; 128(2):223-30. PubMed ID: 26849147
[TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of pocket hematoma after cardiac device implantation and replacement.
Ferretto S; Mattesi G; Migliore F; Susana A; De Lazzari M; Iliceto S; Leoni L; Bertaglia E
J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):123-127. PubMed ID: 31789710
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.
Michaud GF; Pelosi F; Noble MD; Knight BP; Morady F; Strickberger SA
J Am Coll Cardiol; 2000 Jun; 35(7):1915-8. PubMed ID: 10841243
[TBL] [Abstract][Full Text] [Related]
18. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
19. Use of MPH hemostatic powder for electrophysiology device implantation reduces postoperative rates of pocket hematoma and infection.
Reynbakh O; Akhrass P; Souvaliotis N; Pamidimukala CK; Nahar H; Bastawrose J; Boktor P; Aziz JE; Mehta D; Aziz EF
Curr Med Res Opin; 2018 Oct; 34(10):1861-1867. PubMed ID: 29764229
[TBL] [Abstract][Full Text] [Related]
20. Rationale, study design, and pilot phase of tHE Management of AntiThrOMbotic therApy (HEMATOMA) in patients undergoing electrophysiological device surgery: Italian National Multicenter Observational REgistry.
Zacà V; Breschi M; Mandorli A; Panchetti L; Ricciardi G; Viani S; Notarstefano P
J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):897-899. PubMed ID: 28594654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
